Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.320
+0.060 (1.41%)
At close: May 22, 2026, 4:00 PM EDT
4.490
+0.170 (3.94%)
After-hours: May 22, 2026, 6:40 PM EDT
Outset Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Outset Medical stock has a consensus rating of "Buy" and an average price target of $8.33. The average 1-year stock price forecast is 92.82% higher than the current stock price, while the lowest is $7.00 (+62.04%) and the highest is $10 (+131.48%).
Price Target: $8.33 (+92.82%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 12, 2026.
Analyst Ratings
The average analyst rating for Outset Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +247.22% | Feb 12, 2026 |
| Stifel | Stifel | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +85.19% | Jan 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +293.52% | Dec 16, 2025 |
| Stifel | Stifel | Strong Buy Maintains $17 → $14 | Strong Buy | Maintains | $17 → $14 | +224.07% | Nov 11, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +293.52% | Nov 11, 2025 |
Financial Forecast
Revenue This Year
130.43M
from 119.48M
Increased by 9.17%
Revenue Next Year
144.68M
from 130.43M
Increased by 10.93%
EPS This Year
-2.97
from -5.37
EPS Next Year
-2.22
from -2.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 133.9M | 149.8M | |||||
| Avg | 130.4M | 144.7M | |||||
| Low | 122.6M | 136.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 12.1% | 14.9% | |||||
| Avg | 9.2% | 10.9% | |||||
| Low | 2.6% | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -2.96 | -2.12 | |||||
| Avg | -2.97 | -2.22 | |||||
| Low | -2.86 | -2.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.